The Mesothelioma Center News – Page 18
-
Treatment & DoctorsPatients in Alabama diagnosed with peritoneal mesothelioma cancer no longer need to leave the state in pursuit of optimal care and long-term survival.
-
Legislation & Litigation
Johnson & Johnson Bankruptcy Plan Won’t Halt Industrial Talc Lawsuit
Johnson & Johnson may have used a controversial bankruptcy spinoff to avoid almost 40,000 cosmetic talc lawsuits, but it now must face plaintiffs… -
Research & Clinical Trials
Study Finds Benefits to Second Peritoneal Mesothelioma Surgery
Patients with peritoneal mesothelioma cancer can survive considerably longer if they are willing and able to undergo a second aggressive surgery following tumor… -
Asbestos Exposure & Bans
EPA Proposes Asbestos Ban on Chrysotile
The U.S. Environmental Protection Agency proposed a potentially historic ban April 5 that would prohibit all current uses of chrysotile asbestos. Chrysotile is the… -
Legislation & Litigation
Senate Passes Asbestos Awareness Resolution, Inches Closer to Ban
The U.S. Senate unanimously passed its annual National Asbestos Awareness Week resolution, inching closer to long-awaited, much-anticipated legislation to ban the toxic substance. The… -
Asbestos Exposure & Bans
Past Asbestos Testing on Inmates Could Affect J&J Talc Lawsuits
Johnson & Johnson funded a study more than 50 years ago at a Philadelphia prison that injected asbestos into a small number of… -
Legislation & Litigation
$36.5 Million Verdict Could Change Asbestos Litigation in Libby, Montana
A Montana District Court jury recently delivered a $36.5 million verdict in a bellwether case that is expected to significantly change the landscape of… -
Legislation & Litigation
Johnson & Johnson’s Talc Bankruptcy Plan Approved
Much to the ire of plaintiff attorneys across the country, a federal judge in New Jersey granted approval for Johnson & Johnson to… -
Research & Clinical Trials
Mesothelioma Clinical Trial Matches Treatment to Genetic Profiles
Scientists at the University of Leicester in the United Kingdom recently published phase 2 clinical trial results involving abemaciclib, a new genetic therapy for… -
Research & Clinical Trials
NCI Moving Closer to More Effective Treatment for Pleural Mesothelioma
A research team at the National Cancer Institute is developing a novel therapy that could change the treatment paradigm for pleural mesothelioma.